Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation

被引:37
作者
Kato, S
Funakoshi, H
Nakamura, T
Kato, M
Nakano, I
Hirano, A
Ohama, E
机构
[1] Tottori Univ, Fac Med, Inst Neurol Sci, Dept Neuropathol, Yonago, Tottori 6838504, Japan
[2] Osaka Univ, Grad Sch Med, Div Mol Regenerat Med, Course Adv Med, Suita, Osaka 5650871, Japan
[3] Tottori Univ Hosp, Div Pathol, Yonago, Tottori, Japan
[4] Jichi Med Coll, Dept Neurol, Tochigi, Japan
[5] Montefiore Med Ctr, Dept Pathol, Div Neuropathol, Bronx, NY 10467 USA
关键词
amyotrophic lateral sclerosis; hepatocyte growth factor; c-Met; neurotrophic factor; Lewy body like hyaline inclusion;
D O I
10.1007/s00401-003-0708-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To clarify the trophic mechanism of residual anterior horn cells affected by sporadic amyotrophic lateral sclerosis (SALS) and familial ALS (FALS) with superoxide dismutase 1 (SOD1) mutations, we investigated the immunohistochemical expression of hepatocyte growth factor (HGF), a novel neurotrophic factor, and its receptor, c-Met. In normal subjects, immunoreactivity to both anti-HGF and anti-c-Met antibodies was observed in almost all anterior horn cells, whereas no significant immunoreactivity was observed in astrocytes and oligodendrocytes. Histologically, the number of spinal anterior horn cells in ALS patients decreased along with disease progression. Immunohistochemically, the number of neurons negative for HGF and c-Met increased with ALS disease progression. However, throughout the course of the disease, certain residual anterior horn cells co-expressed both HGF and c-Met with the same, or even stronger intensity in comparison with those of normal subjects, irrespective of the reduction in the number of immunopositive cells. Western blot analysis revealed that c-Met was induced in the spinal cord of a patient with SALS after a clinical course of 2.5 years, whereas the level decreased in a SALS patient after a clinical course of 11 years 5 months. These results suggest that the autocrine and/or paracrine trophic support of the HGF-c-Met system contributes to the attenuation of the degeneration of residual anterior horn cells in ALS, while disruption of the neuronal HGF-c-Met system at an advanced disease stage accelerates cellular degeneration and/or the process of cell death. In SOD1-mutated FALS patients, Lewy body-like hyaline inclusions (LBHIs) in some residual anterior horn cells exhibited co-aggregation of both HGF and c-Met, although the cytoplasmic staining intensity for HGF and c-Met in the LBHI-bearing neurons was either weak or negative. Such sequestration of HGF and c-Met in LBHIs may suggest partial disruption of the HGF-c-Met system, thereby contributing to the acceleration of neuronal degeneration in FALS patients.
引用
收藏
页码:112 / 120
页数:9
相关论文
共 42 条
[1]   Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels [J].
Bendotti, C ;
Tortarolo, M ;
Suchak, SK ;
Calvaresi, N ;
Carvelli, L ;
Bastone, A ;
Rizzi, M ;
Rattray, M ;
Mennini, T .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (04) :737-746
[2]   ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions [J].
Bruijn, LI ;
Becher, MW ;
Lee, MK ;
Anderson, KL ;
Jenkins, NA ;
Copeland, NG ;
Sisodia, SS ;
Rothstein, JD ;
Borchelt, DR ;
Price, DL ;
Cleveland, DW .
NEURON, 1997, 18 (02) :327-338
[3]  
Charcot J, 1869, Arch Physiol Neurol Pathol, V2, P744
[4]   EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE CAUSES DELAYED NEUROTOXICITY IN PRIMARY MIXED NEURONAL-GLIAL CORTICAL CULTURES [J].
DAWSON, VL ;
BRAHMBHATT, HP ;
MONG, JA ;
DAWSON, TM .
NEUROPHARMACOLOGY, 1994, 33 (11) :1425-1430
[5]  
Desagher S, 1996, J NEUROSCI, V16, P2553
[6]   Hepatocyte growth factor scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons [J].
Ebens, A ;
Brose, K ;
Leonardo, ED ;
Hanson, MG ;
Bladt, F ;
Birchmeier, C ;
Barres, BA ;
TessierLavigne, M .
NEURON, 1996, 17 (06) :1157-1172
[7]   Hepatocyte growth factor: from diagnosis to clinical applications [J].
Funakoshi, H ;
Nakamura, T .
CLINICA CHIMICA ACTA, 2003, 327 (1-2) :1-23
[8]   Identification of HGF-like protein as a novel neurotrophic factor for avian dorsal root ganglion sensory neurons [J].
Funakoshi, H ;
Nakamura, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (03) :606-612
[9]  
GIORDANO S, 1989, ONCOGENE, V4, P1383
[10]  
Hamanoue M, 1996, J NEUROSCI RES, V43, P554, DOI 10.1002/(SICI)1097-4547(19960301)43:5<554::AID-JNR5>3.0.CO